Guidelines Development Group

The objective of the Guidelines Development Group (GDG) is to develop evidence-based European Guidelines for breast cancer screening and diagnosis (the European Breast Guidelines) for screening and diagnosis.

The GDG will follow the GRADE approach in defining the healthcare question of interest (population of interest, interventions to be compared and patient-relevant outcomes- PICO), synthesizing the evidence and developing the recommendations for the Guidelines. This will be carried out within virtual working environments and in meetings organised every three months. The initial draft documents and the final versions before publication are subject of open calls for feedback launched online.

The members are also invited to contribute to the other ECIBC objectives, the Digital Mammography Training Template and the European Guidelines Platform covering all processes of care (from screening to end-of-life care). 

An external contractor, CCIb –Iberoamerican Cochrane Centre, supports the GDG for their tasks from literature review to drafting of recommendations.

Privacy statement

Members and external experts

Livia Giordano

Livia Giordano

I am a Medical Doctor, working as epidemiologist at the Centre for Cancer Prevention in Turin (Italy) since 1991.

I have broad experience in research encompassing epidemiology, cancer screening, smoking cessation and communication strategies. I have also experience in conducting/analysing intervention studies.

I have been the president of Gisma (the Italian Group for Breast cancer screening programmes) from 2009 to 2015.

My current main activity focuses on breast cancer screening evaluation and implementation both at local and national level. Actually I am a key investigator of a RCT pilot project aiming to widespread healthier lifestyles among the population invited to perform a breast cancer screening (STI.VI trial) and the co-investigator of a project assessing the predictive value of combined risk criteria (breast density,  reproductive factors, lifestyle habits and molecular biomarkers) for tailored breast cancer screening strategies (Andromeda study).

I am also involved in projects on social inequalities and barriers to screening accessibility in disadvantages people and in the evaluation of the sustainability of cancer screening activities in low-resource settings of the Mediterranean area (Euromed study).

I have been one of the authors of the chapters related to communication both in the 'European guidelines for quality assurance in breast cancer screening and diagnosis (fourth edition)' and in the ' European guidelines for quality assurance in colorectal cancer screening and diagnosis (first edition)'.

Declaration of interests



Last update: 2018